Clinical Trial Update: Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma [Phase 3]

View source ↗

Summary

This Phase 3 trial is investigating whether dexrazoxane can prevent heart damage caused by anthracycline chemotherapy in patients with Diffuse Large B-Cell Lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• DEXRAZOXANE (DEXRAZOXANE)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | Phase 3 | Status: RECRUITING